Narrow band UVB phototherapy for patients with Clinically Isolated Syndrome: A phase 1 trial [ 2014 - 2017 ]

Research Grant

Researchers: Prof Prue Hart (Principal investigator) ,  Dr Judy Cole ,  Prof Allan Kermode ,  Prof David Booth ,  Prof David Nolan
View all 7 related researchers

Brief description The environment, particularly lack of sunlight exposure, contributes to the incidence and progression of multiple sclerosis. We will give patients with early multiple sclerosis controlled exposure to ultraviolet light and then measure biomarkers of their disease activity over the next 12 months. The therapy is safe and is used for treatment of patients with psoriasis. Patients should gain benefits from sunlight-induced vitamin D, as well as other sunlight-induced molecules.

Funding Amount $AUD 682,803.89

Funding Scheme Project Grants

Notes Standard Project Grant